![Bill Vincent](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Bill Vincent
Entité | Type d'entité | Industrie | |
---|---|---|---|
Genezen Laboratories, Inc.
![]() Genezen Laboratories, Inc. BiotechnologyHealth Technology Genezen Laboratories, Inc. is a company based in Indianapolis, IN that was founded in 2014 by Bill Vincent. Genezen Laboratories has expansive knowledge and experience in the industry and works with the nation's leading institutions. The company is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide. The company offers early-phase process development, GMP vector production, and analytical testing services to both early-stage, growth-oriented companies and established industry leaders. Steven J. Favaloro has been the CEO of the company since 2023.
2
| Holding Company | Biotechnology | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Bill Vincent via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Ampersand Management LLC
![]() Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Investment Managers | Consultant / Advisor | |
Arbor Biotechnologies, Inc.
![]() Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO | |
Arranta Bio Holdings LLC
![]() Arranta Bio Holdings LLC BiotechnologyHealth Technology Arranta Bio Holdings LLC engages in the provision of contract development and manufacturing services for therapies targeting diseases linked to the human microbiome. It offers media formulation, cell banking, fermentation, cell harvest and downstream process, formulation, lyophilization, drug product finishing, and analytical services. The company was founded by Mark R. Bamforth and Iain Baird in May 2019 and is headquartered in Watertown, MA. | Biotechnology | Director of Finance/CFO | |
Brammer Bio LLC
![]() Brammer Bio LLC Pharmaceuticals: MajorHealth Technology Brammer Bio LLC manufactures pharmaceutical products. The firm’s services include process development, gene therapy manaufacturing and viral vectors. The company was founded by Christopher K. Murphy, Richard O. Snyder, Mark R. Bamforth and Steven H. Kasok in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Boston College | College/University | Undergraduate Degree | |
Wallace E Carroll School of Management | College/University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Opérationnelle
Director of Finance/CFO | 3 |
Chief Operating Officer | 1 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
President | 1 |
Relations les plus connectées
Insiders | |
---|---|
Steven Favaloro | 7 |
Dave Wilhite | 1 |
- Bourse
- Insiders
- Bill Vincent
- Connexions Sociétés